Podme logo
HjemOppdagKategorierSøkStudent
Recode Decode: Whistleblower Aid CEO John Tye

Recode Decode: Whistleblower Aid CEO John Tye

55:062019-09-25

Om episode

John Napier Tye, the founder and CEO of Whistleblower Aid, talks with Recode's Kara Swisher about how his non-profit law firm helps people seeking to legally expose corruption in the government and at private companies. It recently worked with a whistleblower at MIT, connecting them with New Yorker reporter Ronan Farrow to discuss the university's cover-up of funding that had come from convicted sex offender Jeffrey Epstein; Tye also discusses the US official who reported President Trump's phone call with the president of Ukraine, the Edward Snowden leaks in 2013, and how whistleblowers can protect themselves from criticism and retribution. Plus: Will we always need whistleblowers? Featuring: John Napier Tye, founder and CEO of Whistleblower Aid (@wbaidlaw) Hosts: Kara Swisher (@karaswisher), Recode co-founder and editor-at-large More to explore: Subscribe for free to Pivot, Kara’s podcast with NYU Professor Scott Galloway that offer sharp, unfiltered insights into the biggest stories in tech, business, and politics. About Recode by Vox: Recode by Vox helps you understand how tech is changing the world — and changing us. Follow Us: Newsletter: Recode Daily Twitter: @Recode and @voxdotcom ... But enough about us We are conducting an audience survey to better serve you. It takes no more than five minutes, and it really helps out the show. Please take our survey here. Learn more about your ad choices. Visit podcastchoices.com/adchoices

logo

PODME

INFORMASJON

  • Om informasjonskapsler
  • Generelle vilkår
  • Personvernerklæring

LAST NED APPEN

app storegoogle play store

REGION

flag
  • sweden_flag
  • norway_flag
  • finland_flag
redaktorsansvar

Podme arbeider etter Vær Varsom-plakatens regler for god presseskikk. Ansvarlig redaktør og daglig leder er Kristin Ward Heimdal. Redaktør for eksterne innholdssamarbeid er Mathias Thaulow Lisberg.

© Podme AB 2024